BioXcel Therapeutics Inc (NASDAQ:BTAI)
| 19.38 Delayed Data As of Jan 14 |  -0.07 / -0.36%Today’s Change | 18.00 Today|||52-Week Range 67.74 | -4.67% Year-to-Date |
Latest BTAI News | Press Releases
No recent news for BioXcel Therapeutics Inc.
Today’s Trading
| Previous close | 19.45 |
| Today’s open | 19.37 |
| Day’s range | 18.00 - 19.60 |
| Volume | 19,670 |
| Average volume (3 months) | 283,913 |
| Market cap | $541.1M |
Data as of 4:00pm ET, 01/14/2022
Growth & Valuation
| Earnings growth (last year) | -87.24% |
| Earnings growth (this year) | -11.39% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACETAdicet Bio Inc | +0.33 | +2.32% |
| VBIVVBI Vaccines Inc | +0.14 | +7.07% |
| DCPHDeciphera Pharmaceut... | +0.45 | +5.35% |
| SIGASIGA Technologies In... | +0.12 | +1.75% |
Data as of 4:44pm ET, 01/14/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$1.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$82.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
